Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Passage BIO, Inc. (PASG)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| | 10-K | 10-K | 10-K | 10-K | S-1 |
| Revenues | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Gross profit | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Research and development | -2868.4% | -1470.9% | -8178.8% | -5947.6% | -271.9% |
| General and administrative | -1644.7% | -750.7% | -3011.4% | -1390.2% | -27.5% |
| Depreciation | -122.6% | -19.3% | -80.0% | -26.8% | |
| EBIT | 4613.1% | 2321.6% | 11290.2% | 7437.8% | 399.5% |
| Pre-tax income | 4537.5% | 2317.3% | 11223.2% | 9126.8% | 378.8% |
| Income taxes | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | 4537.5% | 2317.3% | 11223.2% | 9126.8% | 378.8% |
|